Fed. Circ. Wrong On HIV Drug Patent Challenge, Justices Hear

By Chuck Stanley · August 13, 2018, 6:55 PM EDT

A health care group told the U.S. Supreme Court it was improperly barred by the Federal Circuit from challenging a patent for an HIV drug because it had not filed an...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Petition

Case Information

Case Title

AIDS Healthcare Foundation v. Gilead Sciences, Inc.

Case Number

Court

Appellate - Federal Circuit

Nature of Suit

830 Patent Infringement (Fed. Question)

Date Filed

August 12, 2016

Recent Articles By Chuck

October 26, 2018
Too Late To Stop Bargain Bin Health Plans, Judge Says
October 23, 2018
Couple Says Gov't 'Ambush' Led To Fraud Convictions
October 04, 2018
Athena Asks Fed. Circ. To Revive Nixed Biotech Patent
August 16, 2018
Antitrust Suit Against Walgreens, Benefits Manager Tossed
August 06, 2018
Dental Cos. Look to Straighten Patent Row In Fed. Circ.
July 11, 2018
FCC Announces $100M Telehealth Pilot Program
June 14, 2018
Aggrenox Buyers Slam Insurers' Bid To Opt Health Plans Out
June 13, 2018
BCBS Can Appeal Ruling That Limits Antitrust MDL Defense
May 24, 2018
Teledentistry Co. Hits Ga. Dentistry Board With Antitrust Suit
May 21, 2018
Highmark Fights Cert. In Antitrust Suit Over Insurance Rates